Publications

Santarosa M, Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochimica et biophysica acta. 2004. PMID: 15172699


Mizenina OA, Moasser MM. S-phase inhibition of cell cycle progression by a novel class of pyridopyrimidine tyrosine kinase inhibitors. Cell cycle (Georgetown, Tex.). 2004. PMID: 15136770


Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA. Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection. Vaccine. 2004. PMID: 15149785


Dhaliwal G, Cornett PA, Tierney LM. Hemolytic anemia. American family physician. 2004. PMID: 15202694


Kelloff GJ, Bast RC, Coffey DS, D'Amico AV, Kerbel RS, Park JW, Ruddon RW, Rustin GJ, Schilsky RL, Sigman CC, Vande Woude GF. Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004. PMID: 15173097


Park JW, Kerbel RS, Kelloff GJ, Barrett JC, Chabner BA, Parkinson DR, Peck J, Ruddon RW, Sigman CC, Slamon DJ. Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004. PMID: 15173098


Small EJ. Monoclonal antibody therapy for prostate cancer: finally a reality? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. PMID: 15173211


Rini BI, Weinberg V, Small EJ. Practice and progress in kidney cancer: methodology for novel drug development. The Journal of urology. 2004. PMID: 15126769


Levy JA, Autran B, Coutinho R, Phair JP. Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. AIDS (London, England). 2004. PMID: 15166523


Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Yen Y, Damon L, Doroshow JH. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. PMID: 15143076


Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM, Munster PN. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. Journal of cellular biochemistry. 2004. PMID: 15108350


Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood. 2004. PMID: 15138164


Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, Bringas JR, Drummond DC, Hong K, Kirpotin DB, McKnight T, Berger MS, Park JW, Bankiewicz KS. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. Journal of neuro-oncology. 2004. PMID: 15174514


Whisenant J, Venook A. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Oncology (Williston Park, N.Y.). 2004. PMID: 15214595


Ryan CJ, Small EJ. Advances in prostate cancer. Current opinion in oncology. 2004. PMID: 15069320


Allen J, Venook A. Hepatocellular carcinoma: epidemic and treatment. Current oncology reports. 2004. PMID: 15066228


Ryan CJ, Small EJ. The selection of hormonal therapy in prostate cancer: who, when, and for how long? Journal of the National Comprehensive Cancer Network : JNCCN. 2004. PMID: 19795609


Melisko ME, Fox R, Venook A. Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clinical oncology (Royal College of Radiologists (Great Britain)). 2004. PMID: 15191008


Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 2004. PMID: 15117761


Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England journal of medicine. 2004. PMID: 15118073